Trials / Unknown
UnknownNCT03899415
TCR-Redirected T Cells Therapy in Patient With HBV Related HCC
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Beijing 302 Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a single center. single arm, open-label study to determine the safety and clinical benefit of TCR-redirected T cell therapy in patient with HBV related HCC post hepatectomy or radiofrequency ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | TCR redirected T cells | HBV antigen specific TCR redirected T cell Infusions. Subjects will receive 1x10\^4 - 5x10\^6 TCR redirected T cells by IV infusion. |
Timeline
- Start date
- 2019-04-20
- Primary completion
- 2022-06-01
- Completion
- 2024-06-01
- First posted
- 2019-04-02
- Last updated
- 2019-04-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03899415. Inclusion in this directory is not an endorsement.